BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33182032)

  • 1. Therapeutic vaccines for colorectal cancer: The progress and future prospect.
    Shahnazari M; Samadi P; Pourjafar M; Jalali A
    Int Immunopharmacol; 2020 Nov; 88():106944. PubMed ID: 33182032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer vaccines: Tumor-associated antigens
    Wagner S; Mullins CS; Linnebacher M
    World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
    Guo M; You C; Dou J
    Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for colorectal cancer: an update.
    Sarvizadeh M; Ghasemi F; Tavakoli F; Sadat Khatami S; Razi E; Sharifi H; Biouki NM; Taghizadeh M
    J Cell Biochem; 2019 Jun; 120(6):8815-8828. PubMed ID: 30536960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for colorectal cancer.
    Zeh HJ; Stavely-O'Carroll K; Choti MA
    Trends Mol Med; 2001 Jul; 7(7):307-13. PubMed ID: 11425639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic cancer vaccines: past, present, and future.
    Guo C; Manjili MH; Subjeck JR; Sarkar D; Fisher PB; Wang XY
    Adv Cancer Res; 2013; 119():421-75. PubMed ID: 23870514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in active specific cancer vaccine treatment for colorectal cancer.
    Okuno K; Sugiura F; Itoh K; Yoshida K; Tsunoda T; Nakamura Y
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1439-45. PubMed ID: 22339221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific vaccines for cancer treatment.
    Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing effective vaccines for colorectal cancer.
    Patel SP; Osada T; Lyerly HK; Morse MA
    Immunotherapy; 2014; 6(8):913-26. PubMed ID: 25313570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade.
    Mougel A; Terme M; Tanchot C
    Front Immunol; 2019; 10():467. PubMed ID: 30923527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside.
    Mocellin S
    Curr Opin Investig Drugs; 2006 Dec; 7(12):1052-61. PubMed ID: 17209522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and prospects in vaccine therapy for gynecologic cancers.
    Gurski KJ; Steller MA
    Oncology (Williston Park); 1997 Nov; 11(11):1727-34, 1739-40; discussion 1740,. PubMed ID: 9394368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer vaccines: what we know and what we don't yet know.
    von Mehren M
    Semin Oncol; 2005 Feb; 32(1):76-84. PubMed ID: 15726509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.